Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses-Reference-Cited by-同舟云学术

Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses

Published:2017-10-09 Issue:7 Volume:16 Page:
ISSN:1871-5273
Container-title:CNS & Neurological Disorders - Drug Targets
language:en
Short-container-title:CNSNDDT

Author:

Kamal Mohammad A.¹,Shakil Shazi²,Nawaz Muhammad S.³,Yu Qian-sheng⁴,Tweedie David⁵,Tan Y.⁶,Qu Xianqin⁶,Greig Nigel H.⁷

Affiliation:

1. King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

2. Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia

3. Department of Biological Science, COMSATS, Islamabad, Pakistan; 4Novel Global Community Educational Foundation, New South Wales, Australia

4. Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, United States

5. Drug Design & Development Section, Laboratory of Neurosciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, United States

6. Department of Medical & Molecular Biosciences, Faculty of Science, University of Technology, Sydney, NSW, Australia

7. Drug Design & Development Section, Gerontology Research Center, Room 4B02, 5600 Nathan Shock Dr., Baltimore, MD 21224, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Neuroscience

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetraselmis chuii Edible Microalga as a New Source of Neuroprotective Compounds Obtained Using Fast Biosolvent Extraction;International Journal of Molecular Sciences;2024-03-31

2. Araucaria heterophylla oleogum resin essential oil is a novel aldose reductase and butyryl choline esterase enzymes inhibitor: in vitro and in silico evidence;Scientific Reports;2023-07-15

3. Multiple Approaches for the Management of Alzheimer's Disease: Natural Compounds, FDA Approved Drugs, and Nanotechnology Interventions;Cellular and Molecular Biology;2022-11-30

4. In depth molecular interaction analyses of the complex of a proposed CTXM-inhibitor bound to the bacterial enzyme;Journal of Biomolecular Structure and Dynamics;2022-10-12

5. Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease;European Journal of Medicinal Chemistry;2022-10